환자 등록 소프트웨어 시장 : 기능별, 유형별, 데이터베이스 유형별, 소프트웨어별, 가격 모델별, 최종 사용자별 - 세계 예측(2025-2030년)

The Patient Registry Software Market was valued at USD 1.58 billion in 2023, expected to reach USD 1.83 billion in 2024, and is projected to grow at a CAGR of 15.89%, to USD 4.44 billion by 2030.

Patient registry software is designed to collect, manage, and utilize data related to patients with specific conditions, diseases, or procedures. This software plays a crucial role in healthcare by facilitating data collection, storage, retrieval, and analysis, thereby helping healthcare providers improve patient outcomes and streamline research efforts. The necessity of patient registry software stems from its ability to enhance the understanding of diseases, support clinical trials, improve treatment protocols, and help policymakers in decision-making. Its applications include clinical research, post-market surveillance of medical products, and personalized medicine, with end-users ranging from hospitals, research centers, pharmaceutical companies to public health organizations.

Market insights indicate that the growth of patient registry software is influenced by the rising need for population health management, increased government initiatives supporting the use of electronic health records, and advancements in healthcare technology. With the growing prevalence of chronic diseases and the shift towards value-based care, there is a significant opportunity for expansion in emerging markets and integration with big data analytics and artificial intelligence. Despite these opportunities, challenges such as data privacy concerns, high implementation costs, and interoperability issues pose limitations to market growth. Furthermore, regulatory hurdles and the reluctance of certain healthcare providers to adopt new technologies may also impact the market.

Innovation and research can focus on enhancing data security, interoperability, and user-friendly interfaces. Integration with telemedicine, IoT, and AI-driven analytics platforms offers potential for business growth. Moreover, expanding capabilities to support real-time data analytics and predictive modeling could provide a competitive edge. The market is inherently dynamic, with trends leaning towards comprehensive systems that offer centralized data access and multifaceted analytics capabilities. Overall, strategically addressing privacy and regulatory concerns while leveraging technological advancements is crucial for capitalizing on emerging opportunities and advancing the patient registry software market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Patient Registry Software Market

The Patient Registry Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases and the urgent need to manage the growing patient pool
  • Government initiatives supporting the digitalization of healthcare infrastructure
  • Expansion of clinical trials and clinical research studies worldwide
• Market Restraints
  • Difficulties associated with integration of patient registry software with healthcare framework
• Market Opportunities
  • Advancements to improve the reliability, performance, and functional features of patient registry software
  • Ongoing regulatory approvals for patient registry software
• Market Challenges
  • Concerns related to data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the Patient Registry Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Patient Registry Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Patient Registry Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Patient Registry Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Patient Registry Software Market

A detailed market share analysis in the Patient Registry Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Patient Registry Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Patient Registry Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Patient Registry Software Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, ArborMetrix, Inc., Cedaron Medical, Inc., Common Management Solutions, S.L., Deutsche Telekom AG, Elekta AB, Epic Systems Corporation, EVADO Pty. Ltd., EvidentIQ Group GmbH, Fivos, Inc., Global Vision Technologies, Inc., Google LLC by Alphabet Inc., Health Catalyst, Inc., Healthmonix, Hewlett Packard Enterprise Development LP, Ifa systems AG, ImageTrend, Inc., Intelerad Medical Systems Incorporated, International Business Machines Corporation, IQVIA Holdings Inc., McKesson Corporation, Microsoft Corporation, Milliman, Inc., MRO Corporation, OpenText Corporation, Optum, Inc., Oracle Corporation, Ordinal Data, Inc., RAYLYTIC GmbH, Seqster PDM, Inc., Syneos Health, Inc., Veradigm LLC, Vitro Software Holdings DAC, and WIRB-Copernicus Group.

Market Segmentation & Coverage

This research report categorizes the Patient Registry Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Function, market is studied across Health Information Exchange, Medical Research & Clinical Studies, Patient Care Management, Point-of-Care, Population Health Management, and Product Outcome Evaluation.
• Based on Type, market is studied across Disease Registries, Health Service Registries, and Product Registries. The Disease Registries is further studied across Asthma Registries, Cancer Registries, Cardiovascular Registries, Chronic Kidney Disease Registries, Diabetes Registries, Orthopedic Registries, and Rare Disease Registries. The Product Registries is further studied across Drug Registries and Medical Device Registries.
• Based on Database Type, market is studied across Commercial Databases and Public Databases.
• Based on Software, market is studied across Integrated Software and Standalone Software.
• Based on Pricing Model, market is studied across Ownership Model and Subscription Model.
• Based on End-User, market is studied across Academic & Research Institutes, Government Organizations, Healthcare Patients, Healthcare Payers, Healthcare Providers, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases and the urgent need to manage the growing patient pool
    • 5.1.1.2. Government initiatives supporting the digitalization of healthcare infrastructure
    • 5.1.1.3. Expansion of clinical trials and clinical research studies worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Difficulties associated with integration of patient registry software with healthcare framework
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements to improve the reliability, performance, and functional features of patient registry software
    • 5.1.3.2. Ongoing regulatory approvals for patient registry software
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to data privacy and security
• 5.2. Market Segmentation Analysis
  • 5.2.1. Function: Significant utility of patient registry software for health information exchange and patient care management
  • 5.2.2. Type: Growing need for health service registries to cater to the broader requirements of healthcare systems
  • 5.2.3. Database Type: Increasing preference toward adopting commercial databases within the patient registry software sector
  • 5.2.4. Software: Widening use of integrated software for seamless integration within larger healthcare ecosystems
  • 5.2.5. Pricing Model: Rising use of the subscription model owing to its ability to provide ongoing updates, support, and scalability
  • 5.2.6. End-User: Government entities with third party administrators (TPAs) are pivotal in advancing the effectiveness and personalization of patient care services
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Patient Registry Software Market, by Function

• 6.1. Introduction
• 6.2. Health Information Exchange
• 6.3. Medical Research & Clinical Studies
• 6.4. Patient Care Management
• 6.5. Point-of-Care
• 6.6. Population Health Management
• 6.7. Product Outcome Evaluation

7. Patient Registry Software Market, by Type

• 7.1. Introduction
• 7.2. Disease Registries
  • 7.2.1. Asthma Registries
  • 7.2.2. Cancer Registries
  • 7.2.3. Cardiovascular Registries
  • 7.2.4. Chronic Kidney Disease Registries
  • 7.2.5. Diabetes Registries
  • 7.2.6. Orthopedic Registries
  • 7.2.7. Rare Disease Registries
• 7.3. Health Service Registries
• 7.4. Product Registries
  • 7.4.1. Drug Registries
  • 7.4.2. Medical Device Registries

8. Patient Registry Software Market, by Database Type

• 8.1. Introduction
• 8.2. Commercial Databases
• 8.3. Public Databases

9. Patient Registry Software Market, by Software

• 9.1. Introduction
• 9.2. Integrated Software
• 9.3. Standalone Software

10. Patient Registry Software Market, by Pricing Model

• 10.1. Introduction
• 10.2. Ownership Model
• 10.3. Subscription Model

11. Patient Registry Software Market, by End-User

• 11.1. Introduction
• 11.2. Academic & Research Institutes
• 11.3. Government Organizations
• 11.4. Healthcare Patients
• 11.5. Healthcare Payers
• 11.6. Healthcare Providers
• 11.7. Pharmaceutical & Biotechnology Companies

12. Americas Patient Registry Software Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Patient Registry Software Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Patient Registry Software Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. HealthVerity FLOW 1.1 Upgraded to Better Contextualize the Patient Journey and Offer Novel Next-Best Actions Across the Life Sciences Industry
  • 15.3.2. Milliman Launches Research Tool Built on CMS Qualified Entity Data
  • 15.3.3. ONCO, Inc. Announces Strategic Partnership with Oncora Medical to Launch Data-Driven Software Automation to Enhance Patient Care and Oncology Data Management
  • 15.3.4. Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions for Patients
  • 15.3.5. Health Catalyst Acquires ERS, Bolsters Tech-Enabled Managed Services Offering with Data Abstraction and Oncology Registry Management Capabilities
  • 15.3.6. PHC Group Completes Acquisition of FUJIFILM Healthcare Systems' Electronic Medical Record and Medical-Receipt Systems Business
  • 15.3.7. Medicare Rolls Out Alzheimer Patient Registry After FDA Approval
  • 15.3.8. Verantos Launches Pragmatic Registry Product and New Registry in Severe Asthma
  • 15.3.9. The SPHERES Registry for NMOSD Patients Launches Precision Medicine Program
  • 15.3.10. Vital Secures USD 24.7 Million in Series B Funding to Advance its Artificial Intelligence-Driven Software for Patients, Hospitals and Health Systems
  • 15.3.11. Nuance and Microsoft Announce the First Fully AI-Automated Clinical Documentation Application for Healthcare
  • 15.3.12. Eka Care, a Startup Helping Digitize Health Records of Indian Patients, Raises USD 15 million

Companies Mentioned

• 1. Accenture PLC
• 2. ArborMetrix, Inc.
• 3. Cedaron Medical, Inc.
• 4. Common Management Solutions, S.L.
• 5. Deutsche Telekom AG
• 6. Elekta AB
• 7. Epic Systems Corporation
• 8. EVADO Pty. Ltd.
• 9. EvidentIQ Group GmbH
• 10. Fivos, Inc.
• 11. Global Vision Technologies, Inc.
• 12. Google LLC by Alphabet Inc.
• 13. Health Catalyst, Inc.
• 14. Healthmonix
• 15. Hewlett Packard Enterprise Development LP
• 16. Ifa systems AG
• 17. ImageTrend, Inc.
• 18. Intelerad Medical Systems Incorporated
• 19. International Business Machines Corporation
• 20. IQVIA Holdings Inc.
• 21. McKesson Corporation
• 22. Microsoft Corporation
• 23. Milliman, Inc.
• 24. MRO Corporation
• 25. OpenText Corporation
• 26. Optum, Inc.
• 27. Oracle Corporation
• 28. Ordinal Data, Inc.
• 29. RAYLYTIC GmbH
• 30. Seqster PDM, Inc.
• 31. Syneos Health, Inc.
• 32. Veradigm LLC
• 33. Vitro Software Holdings DAC
• 34. WIRB-Copernicus Group